Enzosafe-D Tablet is a combination pharmaceutical formulation containing Trypsin 48 mg, Bromelain 90 mg, Rutoside 100 mg, and Diclofenac 50 mg, designed for the management of inflammatory conditions and associated pain. Trypsin and Bromelain are proteolytic enzymes that exert anti-inflammatory and fibrinolytic effects, facilitating the reduction of edema and promoting tissue repair. Rutoside, a bioflavonoid, enhances capillary strength and exhibits antioxidant properties, contributing to the reduction of vascular permeability and inflammation. Diclofenac, a nonsteroidal anti-inflammatory drug (NSAID), provides potent analgesic and anti-inflammatory effects by inhibiting cyclooxygenase enzymes, thereby reducing the synthesis of prostaglandins involved in pain and inflammation pathways. The synergistic action of these components makes Enzosafe-D effective in treating acute musculoskeletal injuries, postoperative inflammation, and chronic inflammatory disorders such as arthritis. It is indicated for conditions requiring rapid relief from pain, swelling, and inflammation. Administration should be as prescribed by a healthcare professional, considering contraindications such as hypersensitivity to NSAIDs, bleeding disorders, or gastrointestinal ulcers. Caution is advised in patients with renal or hepatic impairment. Enzosafe-D should be used under medical supervision to optimize therapeutic outcomes and minimize adverse effects.